The safety and immunogenicity of a prototype vaccine was compared to a previously developed oral ETEC vaccine in a randomized clinical Phase I trial in 59 Swedish volunteers. The volunteers were given two oral doses of either the prototype or the reference vaccine. The prototype vaccine was found to be as safe and equally well […]
The dmLT adjuvant was studied in a dose-escalation clinical phase-I trial evaluating safety and immunogenicity of a single oral administration. The dmLT was safe and well tolerated by the 36 study participants. The study was conducted under an US IND. SS. El-Kamary, Clin Vaccine Immunol 2013. Safety and immunogenicity of a single oral dose of […]
Study OEV-128 – Phase IIB Study in children 6-18 months in The Gambia
Study OEV-124 – Phase I, Age-descending study in Zambia
Study OEV-123 – Phase IIb Safety, diagnostic methodology evaluation and estimated vaccine efficacy in travellers to Benin
Study OEV-122 – Phase I/II, Age descending safety and immunogenicity trial in Bangladesh (age ≥6 mo)
Study OEV-121A – Phase I, Booster dose memory study
Study OEV-121 – Phase I, Safety and immunogenicity of vaccine
Study OEV-120 – Phase I, Safety and immunogenicity of a prototype vaccine
Study DMID 09-066 – Phase I, dmLT adjuvant safety and immunogenicity
